| 1 |
35106936 |
10.1002/cam4.4550 |
2022 |
SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups. |
SGK1 |
| 2 |
32273478 |
10.3324/haematol.2020.251579 |
2021 |
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. |
SGK1 |
| 3 |
33988691 |
10.1182/blood.2020010432 |
2021 |
SGK1 mutations in DLBCL generate hyperstable protein neoisoforms that promote AKT independence. |
SGK1 |
| 4 |
34132431 |
10.1002/ptr.7157 |
2021 |
Suppression of phosphoinositide 3-kinase/phosphoinositide-dependent kinase-1/serum and glucocorticoid-induced protein kinase pathway. |
SGK1 |
| 5 |
34272731 |
10.1111/bjh.17708 |
2021 |
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. |
SGK1 |
| 6 |
34378195 |
10.1111/bjh.17765 |
2021 |
Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort. |
SGK1 |
| 7 |
31958764 |
10.1016/j.biopha.2020.109835 |
2020 |
Clinical characteristics of colorectal cancer patients and anti-neoplasm activity of genistein. |
SGK1 |
| 8 |
32187361 |
10.1182/blood.2019003535 |
2020 |
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. |
SGK1 |
| 9 |
33252851 |
10.1002/ctm2.221 |
2020 |
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. |
SGK1 |
| 10 |
33584271 |
10.3389/fphar.2020.594038 |
2020 |
Piperazine-Derived α<sub>1D/1A</sub> Antagonist 1- Benzyl-N- (3-(4- (2-Methoxyphenyl) Piperazine-1-yl) Propyl) -1H- Indole-2- Carboxamide Induces Apoptosis in Benign Prostatic Hyperplasia Independently of α1-Adrenoceptor Blocking. |
SGK1 |
| 11 |
30213827 |
10.3324/haematol.2018.203224 |
2019 |
<i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma. |
SGK1 |
| 12 |
30694908 |
10.1097/WNR.0000000000001180 |
2019 |
Leonurine promotes neurite outgrowth and neurotrophic activity by modulating the GR/SGK1 signaling pathway in cultured PC12 cells. |
SGK1 |
| 13 |
30926771 |
10.1038/s41408-019-0203-y |
2019 |
Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors. |
SGK1 |
| 14 |
31203134 |
10.1016/j.biopha.2019.109092 |
2019 |
Estradiol promotes trophoblast viability and invasion by activating SGK1. |
SGK1 |
| 15 |
35540673 |
10.1039/c9ra07900a |
2019 |
Retracted Article: Circular RNA hsa_circ_0000467 modulates SGK1 to facilitate cell migration, metastasis, and EMT while repressing apoptosis in colorectal cancer by sponging miR-383-5p. |
SGK1 |
| 16 |
28905990 |
10.1002/ijc.31044 |
2018 |
The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma. |
SGK1 |
| 17 |
30613266 |
10.7150/thno.26888 |
2018 |
Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages. |
SGK1 |
| 18 |
28879465 |
10.1007/s00292-017-0335-4 |
2017 |
[Nodular lymphocyte-dominant Hodgkin's lymphoma : LP cells show recurrent mutations in DUSP2, SGK1 and JUNB]. |
SGK1 |
| 19 |
26658840 |
10.1038/leu.2015.328 |
2016 |
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. |
SGK1 |
| 20 |
26229090 |
10.1158/2159-8290.CD-15-0370 |
2015 |
Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. |
SGK1 |
| 21 |
26380811 |
10.1016/j.fob.2015.08.001 |
2015 |
NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity. |
SGK1 |
Datasets
Models
